Login / Signup

The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study.

Lieke Mitrov-WinkelmolenMarie-Christine W van Buul-GastDingeman J SwankHans W P M OverdiekRon H N van SchaikDaan J Touw
Published in: Obesity surgery (2018)
Our study shows a faster absorption of both ASA and omeprazole after RYGB. The exposure to ASA is higher post-surgery, but the standard dose of 80 mg does not need to be modified, considering its range in effective dose. The exposure to omeprazole is, on average, decreased after surgery. Clinicians should be aware to increase the dose of omeprazole if symptoms suggest inadequate response.
Keyphrases
  • obese patients
  • roux en y gastric bypass
  • bariatric surgery
  • gastric bypass
  • weight loss
  • minimally invasive
  • coronary artery bypass
  • depressive symptoms
  • acute coronary syndrome